CMS finalizes a policy that creates a faster pathway to reimbursement for “breakthrough” medical devices. The FDA approves Purdue Pharma’s opioid overdose-reversal device. And a recent report finds that untreated vision loss and high cholesterol could be risk factors for dementia. That’s coming up on today’s episode of Gist Healthcare Daily.
","author_name":"Gist Healthcare Daily"}